The University of Toledo College of Medicine and Life Sciences is a medical school affiliated with the University of Toledo, a public university located in Toledo, Ohio, United States. The College is located on the University of Toledo's Health Science Campus in south Toledo.

During the past decade, University of Toledo, Health Science Campus conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 11 clinical trials were completed, i.e. on average, 220% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Toledo, Health Science Campus" #1 sponsor was "University of Toledo Health Science Campus" with 17 trials, followed by "Novartis" with 2 trials sponsored, "Bial - Portela C S.A." with 1 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Toledo, Health Science Campus" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "University of Toledo, Health Science Campus" are "Diabetes" (2 trials), "Epilepsy" (2 trials), "Multiple Sclerosis" (2 trials), "Muscle Relaxants" (2 trials) and "Pneumococcal Infection" (2 trials). Many other conditions were trialed in "University of Toledo, Health Science Campus" in a lesser frequency.

Most popular intervention types in "University of Toledo, Health Science Campus" are "Drug" (12 trials), "Device" (5 trials), "Biological" (4 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Low Level Laser Therapy" (2 trials), "1200 mg QD Eslicarbazepine acetate" (1 trials), "13-valent pneumococcal conjugate vaccine" (1 trials) and "23-valent pneumococcal polysaccharide vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Toledo, Health Science Campus" are 26 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Toledo, Health Science Campus". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in University of Toledo, Health Science Campus, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Toledo, Health Science Campus, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".